Vestal Point Capital, LP: UNITED THERAPEUTICS CORP DEL (UTHR): Quarterly 13F Position History
As of Q2 2026, Vestal Point Capital, LP reported 435,000 shares of UNITED THERAPEUTICS CORP DEL (UTHR), worth $235.7M and representing 5.5% of its 13F equity book. Quarter-over-quarter share count change: + 360,000 (+480.0%) . The position first appeared in Q1 2026 and has been disclosed across 2 13F-HR filings in Pactolio's tracked window.
- 435,000Shares Held (Latest Filing)
- $235.7MReported Market Value (Latest Filing)
- 5.5%Portfolio Weight (% of 13F Equity Book)
- +360,000Quarter-over-Quarter Share Change
- +$191.2MQuarter-over-Quarter Value Change
- 435,000Peak Reported Shares (Historical)
Recent initiation: Vestal Point Capital, LP first reported UTHR on the Q1 2026 filing, so fewer than three quarters of history are available.
Quarterly 13F-HR Disclosure History Source: SEC 13F-HR filings, 2 quarter s
| Quarter | Shares | QoQ Share Change | Share Change (%) | Market Value | Weight | Implied Price |
|---|---|---|---|---|---|---|
| Q2 2026 | 435,000 | +360,000 | +480.0% | $235.7M | 5.5% | $541.8 |
| Q1 2026 | 75,000 | – | – | $44.5M | 1.2% | $593.0 |
Methodology & FAQ
How This Position History Is Sourced
Each row is one SEC Form 13F-HR filing disclosing this position. Share count, market value, and reported quarter are taken verbatim from the filing; portfolio weight is recomputed against the same filing's total reported equity book. Implied price-per-share is market value divided by shares, a quarter-end mark rather than the manager's cost basis. See the full methodology document for the normalization rules.
When did Vestal Point Capital, LP first disclose a UTHR position in 13F-HR filings?
Vestal Point Capital, LP first reported UNITED THERAPEUTICS CORP DEL (UTHR) on its 13F-HR filing for the period ending 2026-03-31 (Q1 2026). The position has appeared on 2 reported quarters within Pactolio's tracked window.
What was Vestal Point Capital, LP's most recent quarter-over-quarter share-count change in UTHR?
Between Q1 2026 and Q2 2026, Vestal Point Capital, LP added 360,000 shares of UTHR (+480.0%), bringing the total reported position to 435,000 shares at a market value of $235.7M.
Does the implied price-per-share represent Vestal Point Capital, LP's cost basis in UTHR?
No. The implied price-per-share column is the 13F-HR reported market value divided by reported share count on the filing date (end of quarter). It is a quarter-end mark, not a cost basis or transaction price. Use it as a sanity check on the value column, not as an indicator of the manager's entry or exit price.